-
07:09:41 PM

TNDM Stock News

01/23/23 9:00 AM
Nasdaq : TNDM
acquisition
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, today announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. “AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem’ s portfolio of...
RHEA-AI
neutral
01/19/23 4:05 PM
Nasdaq : TNDM
earnings
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday, February 22, 2023. About Tandem Diabetes Care, Inc.. Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego,...
RHEA-AI
neutral
01/03/23 4:05 PM
Nasdaq : TNDM
conferences
Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:15pm Eastern Time. Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:...
RHEA-AI
neutral
11/10/22 5:22 PM
Nasdaq : TNDM
Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced results from a prospective, multicenter, single-arm study of adults living with type 2 diabetes who achieved improvement in all clinical endpoints with the use of the t: slim X2 insulin pump with Control-IQ technology. 1. “The results presented today are...
RHEA-AI
very positive
11/02/22 4:05 PM
Nasdaq : TNDM
earnings
Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2022 and updated its financial guidance for the year ending December 31, 2022. Worldwide installed base increased 35 percent to more than 400,000 customers. Worldwide sales increased 14 percent to...
RHEA-AI
neutral